Insider Buying: Kailera Therapeutics (NASDAQ:KLRA) Director Purchases $25,000,000.00 in Stock

Kailera Therapeutics, Inc. (NASDAQ:KLRA) Director Adam Koppel bought 1,562,500 shares of the stock in a transaction that occurred on Monday, April 20th. The stock was purchased at an average price of $16.00 per share, for a total transaction of $25,000,000.00. Following the completion of the purchase, the director directly owned 22,583,268 shares in the company, valued at $361,332,288. The trade was a 7.43% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Kailera Therapeutics Stock Performance

NASDAQ KLRA opened at $24.30 on Thursday. Kailera Therapeutics, Inc. has a 52-week low of $23.65 and a 52-week high of $28.23.